Organization
Lucence Diagnostics Pte Ltd
4 abstracts
Abstract
Multi-cancer early detection (MCED) in circulating tumor DNA (ctDNA) using an ultrasensitive mutation-based amplicon next-generation sequencing (NGS) assay.Org: Lucence Diagnostics Pte Ltd,
Abstract
Utility of an amplicon-based ctDNA platform for advanced cholangiocarcinomas (CCA) in asia.Org: Department of Medicine, Icahn School of Medicine at Mount Sinai, The University of Hong Kong, Queen Mary Hospital, Lucence Diagnostics Pte Ltd,
Abstract
Liquid biopsy in combination with PET/CT versus PET/CT alone in diagnosis of lung cancer in small nodules.Org: VA Palo Alto Health Care System, Lucence Health Inc, Lucence Diagnostics Pte. Ltd., Lucence Diagnostics Pte Ltd, Palo Alto Veterans Institute for Research,
Abstract
Assessing the utility of liquid biopsy for detecting actionable genetic mutations among indigenous Ghanaian women with metastatic breast cancer.Org: Yemaachi Biotech, Cape Coast Teaching Hospital, University of Cape Coast, Lucence Diagnostics Pte Ltd, Lucence Health Inc,